Additional US patent is important for the company, CEO says – Video

Posted: Published on August 9th, 2013

This post was added by Dr Simmons




Additional US patent is important for the company, CEO says
Glyn Edwards, CEO of drug discovery company Summit, tells Proactiveinvestors the additional patent for Duchenne Muscular Dystrophy treatment C1100 the compan...

By: ProactiveInvestors

Read this article:
Additional US patent is important for the company, CEO says - Video

Related Posts
This entry was posted in Muscular Dystrophy Treatment. Bookmark the permalink.

Comments are closed.